Journal article · 2021

Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence

Yoshiaki Sato, Ikuo Kashiwakura, Masaru Yamaguchi, Hironori Yoshino, Takeshi Tanaka, Ken Ikeda, Zhengmao Ye, Hirotsugu Komatsu, Takao Matsuzaki, Masato Hosoda

Medicinal Chemistry, 18(6), 694–700 · Published 16 November 2021 · DOI 10.2174/1573406418666211116144243

View at the publisherCite this paper

In brief

“Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence” is a 2021 journal article by Yoshiaki Sato and 9 co-authors, published in Medicinal Chemistry. OpenAlex counts 4 citations as of 21 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
4
Most cited in
2024 (2)
Field-weighted impact
0.21
References
30
Authors
10

Abstract

BACKGROUND: Interleukin-6 (IL-6) is a multifunctional cytokine involved in various cell functions and diseases. Thus far, several IL-6 inhibitors, such as humanized monoclonal antibody have been used to block excessive IL-6 signaling causing autoimmune and inflammatory diseases. However, anti-IL-6 and anti-IL-6 receptor monoclonal antibodies have some clinical disadvantages, such as a high cost, unfavorable injection… Read the full abstract at the publisher.

Excerpt. This paper is not open access.

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Sato, Y., Kashiwakura, I., Yamaguchi, M., Yoshino, H., Tanaka, T., Ikeda, K., Ye, Z., Komatsu, H., Matsuzaki, T., & Hosoda, M. (2021). Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence. Medicinal Chemistry, 18(6), 694–700. https://doi.org/10.2174/1573406418666211116144243

MLA 9

Sato, Yoshiaki, et al. “Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence.” Medicinal Chemistry, vol. 18, no. 6, 2021, pp. 694–700. https://doi.org/10.2174/1573406418666211116144243.

Chicago

Sato, Yoshiaki, Ikuo Kashiwakura, Masaru Yamaguchi, Hironori Yoshino, Takeshi Tanaka, Ken Ikeda, Zhengmao Ye, Hirotsugu Komatsu, Takao Matsuzaki, and Masato Hosoda. 2021. “Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence.” Medicinal Chemistry 18 (6): 694–700. https://doi.org/10.2174/1573406418666211116144243.

Harvard

Sato, Y. et al. (2021) ‘Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence’, Medicinal Chemistry, 18(6), pp. 694–700. doi:10.2174/1573406418666211116144243.

IEEE

Y. Sato et al., “Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence,” Medicinal Chemistry, vol. 18, no. 6, pp. 694–700, 2021, doi: 10.2174/1573406418666211116144243.

BibTeX

@article{sato2021discovery,
  title     = {{Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence}},
  author    = {Sato, Yoshiaki and Kashiwakura, Ikuo and Yamaguchi, Masaru and Yoshino, Hironori and Tanaka, Takeshi and Ikeda, Ken and Ye, Zhengmao and Komatsu, Hirotsugu and Matsuzaki, Takao and Hosoda, Masato},
  journal   = {Medicinal Chemistry},
  year      = {2021},
  volume    = {18},
  number    = {6},
  pages     = {694--700},
  doi       = {10.2174/1573406418666211116144243},
  url       = {https://doi.org/10.2174/1573406418666211116144243}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
202211
202422
202611

Its field-weighted citation impact is 0.21: it has been cited 0.21 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods

  • interleukin-6
  • virtual screening
  • artificial intelligence
  • STAT3 phosphorylation
  • cytokine signaling
  • anti-inflammatory drug discovery
  • autoimmune disease

Work with this paper

Most-cited papers in Pharmacology, Toxicology and Pharmaceutics

All highly cited Pharmacology, Toxicology and Pharmaceutics papers

Questions about this paper

How do I cite this paper in APA style?

Sato, Y., Kashiwakura, I., Yamaguchi, M., Yoshino, H., Tanaka, T., Ikeda, K., Ye, Z., Komatsu, H., Matsuzaki, T., & Hosoda, M. (2021). Discovery of a Novel Small-molecule Interleukin-6 Inhibitor Through Virtual Screening Using Artificial Intelligence. Medicinal Chemistry, 18(6), 694–700. https://doi.org/10.2174/1573406418666211116144243

How many times has this paper been cited?

4 times, according to OpenAlex on 21 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Yoshiaki Sato, Ikuo Kashiwakura, Masaru Yamaguchi, Hironori Yoshino, Takeshi Tanaka, Ken Ikeda, Zhengmao Ye, Hirotsugu Komatsu, Takao Matsuzaki, Masato Hosoda.

What is the DOI of this paper?

10.2174/1573406418666211116144243, permanently at https://doi.org/10.2174/1573406418666211116144243. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 21 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.